Keyphrases
Comorbidity
100%
Tinnitus
95%
Head-and-neck Cancer
85%
Staging System
50%
Chronic Rhinosinusitis
50%
Confidence Interval
43%
Randomized Clinical Trial
35%
Head-and-neck
32%
Severity Staging
30%
Otolaryngology
29%
Clinical Severity
27%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
27%
Outcomes Research
25%
Overall Survival
25%
Olfactory Dysfunction
25%
5-year Survival
21%
Odds Ratio
20%
Dural Arteriovenous Fistula (dAVF)
19%
Cancer Patients
19%
Sino-Nasal Outcome Test
18%
Tinnitus Handicap Inventory
17%
Risk Factors
17%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
17%
High-risk Human Papillomavirus (HR-HPV)
17%
Ecological Momentary Assessment
16%
Comorbidity Index
16%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
16%
Tumor
16%
Hereditary Hemorrhagic Telangiectasia
16%
Quality of Life
15%
Hearing Impairment
15%
Sinusitis
15%
Treatment Efficacy
15%
COVID-19
15%
TNM Staging
14%
Placebo
14%
Functional Endoscopic Sinus Surgery
14%
University of Washington
14%
Clinical Trials
14%
P16-positive
13%
Computed Tomography
13%
Patient-centered
13%
Rhinosinusitis
13%
Functional Connectivity
13%
Chemotherapy
13%
Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS)
13%
Adult Comorbidity Evaluation-27
13%
Chiari Malformation Type I
12%
Neural Connectivity
12%
Neoadjuvant
12%
Medicine and Dentistry
Head and Neck Cancer
70%
Malignant Neoplasm
63%
Comorbidity
58%
Disease
54%
Chronic Rhinosinusitis
45%
Neoplasm
36%
Randomized Clinical Trial
32%
Overall Survival
30%
Quality of Life
29%
Symptom
25%
Neck
24%
Otorhinolaryngology
23%
Surgery
23%
COVID-19
22%
Functional Endoscopic Sinus Surgery
20%
Recurrent Disease
20%
Wart Virus
19%
Dural Arteriovenous Fistula
19%
Arnold Chiari Malformation
19%
Survival Rate
19%
Squamous Cell Carcinoma
19%
Odor
18%
Cancer Staging
18%
Combination Therapy
18%
Tinnitus
18%
Placebo
17%
P16
17%
Rhinosinusitis
17%
Sinusitis
17%
Hazard Ratio
16%
Oropharynx Squamous Cell Carcinoma
16%
Obstructive Sleep Apnea
15%
Hearing Impairment
14%
Computer Assisted Tomography
14%
Odds Ratio
14%
Radiation Therapy
13%
Nasal Polyp
13%
Head and Neck Surgery
13%
Multivariate Analysis
13%
Psychometry
13%
Odds Ratio
13%
Patient-Reported Outcome
13%
Clinical Trial
12%
Hereditary Hemorrhagic Telangiectasia
12%
Spine Surgery
12%
Oropharynx Carcinoma
12%
Head and Neck Squamous Cell Carcinoma
12%
Larynx
12%
Systematic Review
12%
Infection
12%